Zoetis Inc. vs Eli Lilly & Co.
ZTS vs LLY — side-by-side comparison from reported financials. ZTS leads 4, LLY leads 7 of 11 comparable metrics.
Zoetis Inc.
ZTS · Healthcare
$73.90+1.12%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ZTS | LLY |
|---|---|---|
| Price | $73.90 | $1 177.20 |
| Market cap | $30.5B | $1.05T |
| Revenue (TTM) | $9.52B | $79.7B |
| Revenue growth | +5.4% | +31.7% |
| Net margin | 27.5% | 33.5% |
| Free cash flow | $2.37B | $18.2B |
| Net cash (debt) | ($6.73B) | ($35.2B) |
| 1-year price return | -48.5% | +37.6% |
| P/E | 11.8 | 41.6 |
| P/E vs own history (cheap-side %) | 97% | 88% |
| Dividend yield | 2.89% | 0.52% |
| Return on equity | 69% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 14,500 | 50,000 |
Full résumé-style profiles: ZTS CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.